Prima Biomed trial results positive

Prima Biomed says initial results from a clinical trial to assess the safety of a breast cancer treatment have been positive.

Biotech Prima Biomed has released positive results from a clinical trial of its lead product to treat metastatic breast cancer.

Prima said on Thursday that the initial data from the trial confirmed that its IMP321 product was safe and well tolerated in patients when used in combination with chemotherapy.

Shares in Prima Biomed were 0.1 cent, or 2.7 per cent, higher at 3.8 cents at 1019 AEDT.

1 min read

Published 22 December 2016 10:36am

Source: AAP

Recommended for you

A silhouette of a woman sitting at a computer with her head resting on her fists

Alana was shocked when her boss shared her diagnosis in public. What does the law say?

privacy breaches

An older woman walking. Houses are in the background.

Tanya is 79 and owns a $2.5 million home. She lives with young housemates

renting

An ambulance outside Bangkok Hospital in Thailand.

Why methanol is a 'silent killer' — and where poisonings happen most

poisoning

A split image. On the left are two women seated on a couch. On the right is a man speaking.

Worse than Sydney: The renters bearing the brunt of unaffordable Perth

renting

A composite image of Penny Wong and Benjamin Netanyahu.

Wong responds to Netanyahu's ICC arrest warrant as US labels move 'outrageous'

2024 mideast wars

Two men in suits sit at a table with papers in front of them, pointing to a section of a document.

'Families are going to be ripped apart': Labor's 'brutal' migration law trio, explained

immigration laws

A split image featuring three photos of Australian brush turkeys.

They aren't 'particularly smart'. But this bird is back in a big way in some parts of Australia

birdwatching

Five cocktails in transparent glasses are arranged on a bar counter.

Methanol poisoning: How risky are our drinks and how can you protect yourself?

biodiesel manufacturing